Effect of the START-Play Physical Therapy Intervention on Cognitive Skills Depends on Caregiver-Provided Learning Opportunities.


Journal

Physical & occupational therapy in pediatrics
ISSN: 1541-3144
Titre abrégé: Phys Occup Ther Pediatr
Pays: England
ID NLM: 8109120

Informations de publication

Date de publication:
2022
Historique:
pubmed: 31 3 2022
medline: 24 8 2022
entrez: 30 3 2022
Statut: ppublish

Résumé

This study evaluated whether caregiver-provided learning opportunities moderated the effect of START-Play physical therapy intervention on the cognitive skills of young children with neuromotor delays, and whether START-Play impacted caregiver-provided learning opportunities over time. One hundred and twelve children with neuromotor delays (7-16 months) participated in a multisite randomized clinical trial evaluating the efficacy of START-Play. Children were assessed at baseline and 3 (post intervention), 6, and 12 months post baseline. Cognition was scored from the Bayley Scales of Infant & Toddler Development, Third Edition, cognitive scale. The proportion of time caregivers spent providing learning opportunities was coded from a 5-minute caregiver-child free play interaction. Baseline caregiver-provided learning opportunities moderated the 3- and 12-month effects of START-Play on cognition. Cognitive gains due to START-Play were more pronounced for children whose caregivers provided more learning opportunities. START-Play did not impact caregiver-provided learning opportunities over time. START-Play may have a lasting effect on children's cognition, but this effect is contingent on caregivers providing their child with ample opportunities to practice cognitive skills. Strategies for improving caregivers' uptake and transfer of START-Play principles to their daily routines should be evaluated. ClinicalTrials.gov NCT02593825.

Identifiants

pubmed: 35350970
doi: 10.1080/01942638.2022.2054301
doi:

Banques de données

ClinicalTrials.gov
['NCT02593825']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

510-525

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD101900
Pays : United States

Auteurs

Natalie A Koziol (NA)

University of Nebraska-Lincoln, Lincoln, Nebraska, USA.

Christiana D Butera (CD)

University of Southern California, Los Angeles, California, USA.

Kari S Kretch (KS)

University of Southern California, Los Angeles, California, USA.

Regina T Harbourne (RT)

Duquesne University, Pittsburgh, Pennsylvania, USA.

Michele A Lobo (MA)

University of Delaware, Newark, Delaware, USA.

Sarah W McCoy (SW)

University of Washington, Seattle, Washington, USA.

Lin-Ya Hsu (LY)

University of Washington, Seattle, Washington, USA.

Sandra L Willett (SL)

Munroe Meyer Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Audrey E Kane (AE)

Virginia Commonwealth University, Richmond, Virginia, USA.

James A Bovaird (JA)

University of Nebraska-Lincoln, Lincoln, Nebraska, USA.

Stacey C Dusing (SC)

University of Southern California, Los Angeles, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH